Similar Papers

Paper Title
Journal
Date
Author
High‐risk human papillomavirus DNA testing and high‐grade cervical intraepithelial lesions
Ke You ... Xueai Liang
Australian and New Zealand Journal of Obstetrics and Gynaecology | VOL. 47
Ke You, et. al.Ke You ... Xueai Liang
08 Mar 2007
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities
Thomas C Wright ... Edward J Wilkinson
Journal of Lower Genital Tract Disease | VOL. 6
Thomas C Wright, et. al.Thomas C Wright ... Edward J Wilkinson
01 Apr 2002
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China
Fang-Hui Zhao ... Rong Zhang
The Lancet Oncology | VOL. 11
Fang-Hui Zhao, et. al.Fang-Hui Zhao ... Rong Zhang
11 Nov 2010
Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample
Chengquan Zhao ... R Marshall Austin
Cancer | VOL. 114
Chengquan Zhao, et. al.Chengquan Zhao ... R Marshall Austin
16 May 2008
View more papers

More From: BMJ Open

Paper Title
Journal
Date
Author
Efficacy of yeast beta-glucan 1,3/1,6 supplementation on respiratory infection, fatigue, immune markers and gut health among moderate stress adults in Klang Valley of Malaysia: protocol for a randomised, double-blinded, placebo-controlled, parallel-group study
Nur Nadia Mohamad Habibullah ... Kalavathy Ramasamy
BMJ Open | VOL. 15
Nur Nadia Mohamad Habibullah, et. al.Nur Nadia Mohamad Habibullah ... Kalavathy Ramasamy
20 Jan 2025
DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care
Angela Edith Schulthess-Lisibach ... Enriqueta Vallejo-Yagüe
BMJ Open | VOL. 15
Angela Edith Schulthess-Lisibach, et. al.Angela Edith Schulthess-Lisibach ... Enriqueta Vallejo-Yagüe
20 Jan 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial
Melanie Varley ... Mark Tuthill
BMJ Open | VOL. 15
Melanie Varley, et. al.Melanie Varley ... Mark Tuthill
20 Jan 2025
Collaboration between ambulance services and primary care: a scoping review protocol
Ann-Therese Hedqvist ... Elin-Sofie Forsgärde
BMJ Open | VOL. 15
Ann-Therese Hedqvist, et. al.Ann-Therese Hedqvist ... Elin-Sofie Forsgärde
15 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.